메뉴 건너뛰기




Volumn 81, Issue 6, 2006, Pages 573-584

Porphyria cutanea tarda;Porfiria cutânea tardia

Author keywords

Chloroquine; Fluorescent antibody technique; Porphyria cutanea tarda complications; Porphyria cutanea tarda pathology; Porphyria cutanea tarda pathophysiology; Porphyria cutanea tarda therapy; Precipitating factors

Indexed keywords

CHLOROQUINE;

EID: 34248642834     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962006000600010     Document Type: Review
Times cited : (14)

References (141)
  • 2
    • 0033010413 scopus 로고    scopus 로고
    • Porphyria cutanea tarda. Don't forget to look at the urine
    • Rich MW. Porphyria cutanea tarda. Don't forget to look at the urine. Postgrad Med. 1999;105:208-10, 213-4.
    • (1999) Postgrad Med , vol.105
    • Rich, M.W.1
  • 4
    • 0002344142 scopus 로고    scopus 로고
    • The cutaneous porphyrias
    • New York: Oxford University Press;
    • Elder GH. The cutaneous porphyrias. In: Hawk JLM. Photodermatology. New York: Oxford University Press; 1999. p.171-97.
    • (1999) Hawk JLM. Photodermatology , pp. 171-197
    • Elder, G.H.1
  • 5
    • 0029127380 scopus 로고
    • The difference in liver pathology between sporadic and familial form of porphyria cutanea tarda: The role of iron
    • Siersema PD, Rademakers LH, Cleton MI, ten Kate FJ, de Bruijn WC, Marx JJ, et al. The difference in liver pathology between sporadic and familial form of porphyria cutanea tarda: the role of iron. J Hepatol. 1995;23:259-67.
    • (1995) J Hepatol , vol.23 , pp. 259-267
    • Siersema, P.D.1    Rademakers, L.H.2    Cleton, M.I.3    ten Kate, F.J.4    de Bruijn, W.C.5    Marx, J.J.6
  • 7
    • 0037259260 scopus 로고    scopus 로고
    • Familial and sporadic porphyria cutanea tarda: Clinical, biochemical and genetic features with emphasis on iron status
    • Bygum A, Christiansen L, Peterson NE, Horder M, Thomsen K, Brandrup F. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status. Acta Derm Venereol. 2003;83:115-20.
    • (2003) Acta Derm Venereol , vol.83 , pp. 115-120
    • Bygum, A.1    Christiansen, L.2    Peterson, N.E.3    Horder, M.4    Thomsen, K.5    Brandrup, F.6
  • 8
    • 0017168895 scopus 로고
    • An inherited enzymatic defect in porphyria cutanea tarda: Decreased uroporphyrinogen decarboxylase activity
    • Kushner JP, Barbuto AJ, Lee GR. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity. J Clin Invest. 1976;58:1089-97.
    • (1976) J Clin Invest , vol.58 , pp. 1089-1097
    • Kushner, J.P.1    Barbuto, A.J.2    Lee, G.R.3
  • 9
    • 0031599775 scopus 로고    scopus 로고
    • Mutations in the hemochromatosis (HFE) gene, porphyria cutanea tarda and iron overload
    • Elder GH, Worwood M. Mutations in the hemochromatosis (HFE) gene, porphyria cutanea tarda and iron overload. Hepatology. 1998;27:289-91.
    • (1998) Hepatology , vol.27 , pp. 289-291
    • Elder, G.H.1    Worwood, M.2
  • 10
    • 0024452072 scopus 로고
    • Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: A study of 40 consecutive patients
    • Held JL, Sassa S, Attalah K, Harber LC. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients. J Invest Dermatol. 1989;93:332-4.
    • (1989) J Invest Dermatol , vol.93 , pp. 332-334
    • Held, J.L.1    Sassa, S.2    Attalah, K.3    Harber, L.C.4
  • 11
    • 0031892668 scopus 로고    scopus 로고
    • Porphyria cutanea tarda
    • Elder GH. Porphyria cutanea tarda. Semin Liver Dis. 1998;18:67-75.
    • (1998) Semin Liver Dis , vol.18 , pp. 67-75
    • Elder, G.H.1
  • 12
    • 84920238259 scopus 로고
    • Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda
    • Elder GH, Urquhart AJ, de Salamanca RE, Munoz JJ, Bonkovsky H. Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet. 1985;2:229-32.
    • (1985) Lancet , vol.2 , pp. 229-232
    • Elder, G.H.1    Urquhart, A.J.2    de Salamanca, R.E.3    Munoz, J.J.4    Bonkovsky, H.5
  • 14
    • 0034520175 scopus 로고    scopus 로고
    • Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda - suggestions for a handling programme
    • Thunell S, Harper P. Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda - suggestions for a handling programme. Scand J Clin Lab Invest. 2000;60:561-79.
    • (2000) Scand J Clin Lab Invest , vol.60 , pp. 561-579
    • Thunell, S.1    Harper, P.2
  • 15
    • 0018084610 scopus 로고
    • Familial and sporadic porphyria cutanea tarda: Two different diseases
    • DeVerneuil H, Aitkne G, Nordmann Y. Familial and sporadic porphyria cutanea tarda: two different diseases. Hum Genet. 1978;44:145-51.
    • (1978) Hum Genet , vol.44 , pp. 145-151
    • DeVerneuil, H.1    Aitkne, G.2    Nordmann, Y.3
  • 16
    • 0026043373 scopus 로고
    • Porphyria cutanea tarda: Erythrocyte uroporphyrinogen decarboxylase activity in 471 consecutive patients
    • Doss MO, Frank M, Braun-Falco O. Porphyria cutanea tarda: erythrocyte uroporphyrinogen decarboxylase activity in 471 consecutive patients. Curr Probl Dermatol. 1991;20:97-105.
    • (1991) Curr Probl Dermatol , vol.20 , pp. 97-105
    • Doss, M.O.1    Frank, M.2    Braun-Falco, O.3
  • 17
    • 0033981851 scopus 로고    scopus 로고
    • Molecular aspects of the inherited porphyrias
    • Sassa S, Kappas A. Molecular aspects of the inherited porphyrias. J Intern Med. 2000;247:169-78.
    • (2000) J Intern Med , vol.247 , pp. 169-178
    • Sassa, S.1    Kappas, A.2
  • 18
    • 0033739090 scopus 로고    scopus 로고
    • Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda
    • Brady JJ, Jackson HA, Roberts AG, Morgan RR, Whatley SD, Rowlands GL, et al. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda. J Invest Dermatol. 2000;115:868-74.
    • (2000) J Invest Dermatol , vol.115 , pp. 868-874
    • Brady, J.J.1    Jackson, H.A.2    Roberts, A.G.3    Morgan, R.R.4    Whatley, S.D.5    Rowlands, G.L.6
  • 19
    • 0024401313 scopus 로고
    • Familial porphyria cutanea tarda with normal erythrocytic urodecarboxylase: An exception to the rule?
    • D'Alessandro Gandolfo L, Griso D, Macri A, Biolcati G, Topi GC. Familial porphyria cutanea tarda with normal erythrocytic urodecarboxylase: an exception to the rule? Dermatologica. 1989;178:206-8.
    • (1989) Dermatologica , vol.178 , pp. 206-208
    • D'Alessandro Gandolfo, L.1    Griso, D.2    Macri, A.3    Biolcati, G.4    Topi, G.C.5
  • 20
    • 0021131935 scopus 로고
    • Porphyria turcica due to hexachlorobenzene - a 20 to 30 year follow-up study on 204 patients
    • Cripps DJ, Peters HA, Gocmen A, Dogramici I. Porphyria turcica due to hexachlorobenzene - a 20 to 30 year follow-up study on 204 patients. Br J Dermatol. 1984;111:413-22.
    • (1984) Br J Dermatol , vol.111 , pp. 413-422
    • Cripps, D.J.1    Peters, H.A.2    Gocmen, A.3    Dogramici, I.4
  • 23
    • 34248659001 scopus 로고    scopus 로고
    • Bickers DR, Pathak MA. The porphyrias. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF. Dermatology in General medicine. 4th ed. New York: McGraw-Hill; 1995. p.1854-93.
    • Bickers DR, Pathak MA. The porphyrias. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF. Dermatology in General medicine. 4th ed. New York: McGraw-Hill; 1995. p.1854-93.
  • 24
    • 0002901758 scopus 로고
    • Porphyria cutanea tarda: A multifactorial disease
    • Champion RH, Pye RJ, eds, Edinburgh: Churchill Livingstone;
    • Elder GH. Porphyria cutanea tarda: a multifactorial disease. In: Champion RH, Pye RJ, eds. Recent advances in dermatology. Edinburgh: Churchill Livingstone; 1990. p.55-70.
    • (1990) Recent advances in dermatology , pp. 55-70
    • Elder, G.H.1
  • 25
    • 0023900839 scopus 로고
    • Role of iron in the hydrogen peroxide-dependent oxidation of hexahydroporphyrins (porphyrinogens): A possible mechanism for the exacerbation by iron of hepatic uroporphyria
    • De Matteis F. Role of iron in the hydrogen peroxide-dependent oxidation of hexahydroporphyrins (porphyrinogens): a possible mechanism for the exacerbation by iron of hepatic uroporphyria. Mol Pharmacol. 1988;33:463-9.
    • (1988) Mol Pharmacol , vol.33 , pp. 463-469
    • De Matteis, F.1
  • 27
    • 34248673858 scopus 로고    scopus 로고
    • De Matteis F. Drug induced abnormalities of liver heme biosynthesis. In: Meeks RG, Harrison SD, Bull RJ. Hepatotoxicology. Boston: CRC press; 1991. p.437-79.
    • De Matteis F. Drug induced abnormalities of liver heme biosynthesis. In: Meeks RG, Harrison SD, Bull RJ. Hepatotoxicology. Boston: CRC press; 1991. p.437-79.
  • 28
    • 0023927521 scopus 로고
    • Oxidation of uroporphyrinogens by hydroxyl radicals: Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase
    • Francis JE, Smith AG. Oxidation of uroporphyrinogens by hydroxyl radicals: evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase. Febs Lett. 1988;233:311-4.
    • (1988) Febs Lett , vol.233 , pp. 311-314
    • Francis, J.E.1    Smith, A.G.2
  • 30
    • 0022586478 scopus 로고
    • Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases
    • Sweeney GD. Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases. Clin Biochem. 1986;19:3-14.
    • (1986) Clin Biochem , vol.19 , pp. 3-14
    • Sweeney, G.D.1
  • 32
    • 0001723307 scopus 로고
    • Untersuchungen über die biologische (photodynamische) Wirkung dês Hämatopophyrins und anderer Derivate des Blut und Gallenfarbstoffs
    • Meyer-Betz F. Untersuchungen über die biologische (photodynamische) Wirkung dês Hämatopophyrins und anderer Derivate des Blut und Gallenfarbstoffs. Dtsch Arch Klin Med. 1913;112:476-503.
    • (1913) Dtsch Arch Klin Med , vol.112 , pp. 476-503
    • Meyer-Betz, F.1
  • 33
    • 0021673220 scopus 로고
    • Activation of the complement system in patients with porphyrias after irradiation in vivo
    • Lim HW, Poh-Fitzpatrick MB, Gigli I. Activation of the complement system in patients with porphyrias after irradiation in vivo. J Clin Invest. 1984;74:1961-5.
    • (1984) J Clin Invest , vol.74 , pp. 1961-1965
    • Lim, H.W.1    Poh-Fitzpatrick, M.B.2    Gigli, I.3
  • 34
    • 0023150122 scopus 로고
    • Differential effects of protoporphyrin and uroporphyrin on murine mast cells
    • Lim HW, Gigli I, Wasserman SI. Differential effects of protoporphyrin and uroporphyrin on murine mast cells. J Invest Dermatol. 1987;88:281-6.
    • (1987) J Invest Dermatol , vol.88 , pp. 281-286
    • Lim, H.W.1    Gigli, I.2    Wasserman, S.I.3
  • 35
    • 0024604630 scopus 로고
    • A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative-mediated cutaneous photosensitization. Activation of the xanthine oxidase pathway
    • Athar M, Elmets CA, Bickers DR, Mukhtar H. A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative-mediated cutaneous photosensitization. Activation of the xanthine oxidase pathway. J Clin Invest. 1989;83:1137-43.
    • (1989) J Clin Invest , vol.83 , pp. 1137-1143
    • Athar, M.1    Elmets, C.A.2    Bickers, D.R.3    Mukhtar, H.4
  • 37
    • 0015619011 scopus 로고
    • Cutaneous changes in the porphyrias: A microscopic study
    • Epstein JH, Tuffanelli DL, Epstein WL. Cutaneous changes in the porphyrias: a microscopic study. Arch Dermatol. 1973;107:689-98.
    • (1973) Arch Dermatol , vol.107 , pp. 689-698
    • Epstein, J.H.1    Tuffanelli, D.L.2    Epstein, W.L.3
  • 38
    • 0015170482 scopus 로고
    • Histopathology of skin in acquired and hereditary porphyria cutanea tarda
    • Cormane RH, Szabò E, Hoo TT. Histopathology of skin in acquired and hereditary porphyria cutanea tarda. Br J Dermatol. 1971;85:531-9.
    • (1971) Br J Dermatol , vol.85 , pp. 531-539
    • Cormane, R.H.1    Szabò, E.2    Hoo, T.T.3
  • 39
    • 0021919461 scopus 로고
    • Activation of complement by 405-nm light in serum from porphyria cutanea tarda
    • Torinuki W, Miura T, Tagami H. Activation of complement by 405-nm light in serum from porphyria cutanea tarda. Arch Dermatol Res. 1985;277:174-8.
    • (1985) Arch Dermatol Res , vol.277 , pp. 174-178
    • Torinuki, W.1    Miura, T.2    Tagami, H.3
  • 40
    • 0019370332 scopus 로고
    • Role of complement in porphyrin-induced photosensitivity
    • Lim HW, Gigli I. Role of complement in porphyrin-induced photosensitivity. J Invest Dermatol. 1981;76:4-9.
    • (1981) J Invest Dermatol , vol.76 , pp. 4-9
    • Lim, H.W.1    Gigli, I.2
  • 41
    • 0016504368 scopus 로고
    • Erythropoietic protoporphyria- submicroscopic events during the acute photosensitivity flare
    • Schnait FG, Wolff K, Konrad K. Erythropoietic protoporphyria- submicroscopic events during the acute photosensitivity flare. Br J Dermatol. 1975;92:545-57.
    • (1975) Br J Dermatol , vol.92 , pp. 545-557
    • Schnait, F.G.1    Wolff, K.2    Konrad, K.3
  • 42
    • 0020041315 scopus 로고
    • Uroporphyrin I stimulation of collagen biosynthesis in human skin fibroblasts. A unique dark effect of porphyrin
    • Varigos G, Schiltz JR, Bickers DR. Uroporphyrin I stimulation of collagen biosynthesis in human skin fibroblasts. A unique dark effect of porphyrin. J Clin Invest. 1982;69:129-35.
    • (1982) J Clin Invest , vol.69 , pp. 129-135
    • Varigos, G.1    Schiltz, J.R.2    Bickers, D.R.3
  • 43
    • 0024520570 scopus 로고
    • Increased mast cell numbers in the sclerotic skin of Porphyria cutanea tarda
    • Torinuki W, Kudoh K, Tagami H. Increased mast cell numbers in the sclerotic skin of Porphyria cutanea tarda. Dermatologica. 1989;178:75-8.
    • (1989) Dermatologica , vol.178 , pp. 75-78
    • Torinuki, W.1    Kudoh, K.2    Tagami, H.3
  • 44
    • 0024971841 scopus 로고
    • Release of prostaglandin E2 from cells by photodynamic treatment in vitro
    • Henderson BW, Donovan JM. Release of prostaglandin E2 from cells by photodynamic treatment in vitro. Cancer Res. 1989;49:6896-900.
    • (1989) Cancer Res , vol.49 , pp. 6896-6900
    • Henderson, B.W.1    Donovan, J.M.2
  • 45
    • 0020349463 scopus 로고
    • Porphyrin-induced photodamage as related to the subcellular localization of the porphyrins
    • Sandberg S, Romslo I, Hovding G, Bjorndal T. Porphyrin-induced photodamage as related to the subcellular localization of the porphyrins. Acta Derm Venereol Suppl (Stockh). 1982;100:75-80.
    • (1982) Acta Derm Venereol Suppl (Stockh) , vol.100 , pp. 75-80
    • Sandberg, S.1    Romslo, I.2    Hovding, G.3    Bjorndal, T.4
  • 46
    • 0029815199 scopus 로고    scopus 로고
    • Photosensitization of uroporphyrin augments the ultraviolet A-induced synthesis of matrix metalloproteinases in human dermal fibroblasts
    • Herrmann G, Wlaschek M, Bolsen K, Prenzel K, Goerz G, Scharffetter-Kochanek K. Photosensitization of uroporphyrin augments the ultraviolet A-induced synthesis of matrix metalloproteinases in human dermal fibroblasts. J Invest Dermatol. 1996;107:398-403.
    • (1996) J Invest Dermatol , vol.107 , pp. 398-403
    • Herrmann, G.1    Wlaschek, M.2    Bolsen, K.3    Prenzel, K.4    Goerz, G.5    Scharffetter-Kochanek, K.6
  • 47
    • 0001169952 scopus 로고
    • Adult form of chronic porphyria with cutaneous manifestations. Report of seventeen additional cases
    • Brunsting LA, Mason HL, Aldrich RA. Adult form of chronic porphyria with cutaneous manifestations. Report of seventeen additional cases. J Am Med Assoc. 1951;146:1207-12.
    • (1951) J Am Med Assoc , vol.146 , pp. 1207-1212
    • Brunsting, L.A.1    Mason, H.L.2    Aldrich, R.A.3
  • 50
    • 0015511393 scopus 로고
    • Hepatic porphyrins and urinary porphyrins and porphyrin precursors in liver cirrhosis
    • Doss M, Look D, Henning H, Nawrocki P, Schmidt A, Dolle W, et al. Hepatic porphyrins and urinary porphyrins and porphyrin precursors in liver cirrhosis. Klin Wochenshr. 1972;50:1025-32.
    • (1972) Klin Wochenshr , vol.50 , pp. 1025-1032
    • Doss, M.1    Look, D.2    Henning, H.3    Nawrocki, P.4    Schmidt, A.5    Dolle, W.6
  • 51
    • 0019985082 scopus 로고
    • Hepatic iron stores and markers of iron overload in alcoholics and patients with hemochromatosis
    • Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with hemochromatosis. Dig Dis Sci. 1982;27:909-16.
    • (1982) Dig Dis Sci , vol.27 , pp. 909-916
    • Chapman, R.W.1    Morgan, M.Y.2    Laulicht, M.3    Hoffbrand, A.V.4    Sherlock, S.5
  • 53
    • 0034161367 scopus 로고    scopus 로고
    • Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda
    • Bulaj ZJ, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood. 2000;95:1565-71.
    • (2000) Blood , vol.95 , pp. 1565-1571
    • Bulaj, Z.J.1    Phillips, J.D.2    Ajioka, R.S.3    Franklin, M.R.4    Griffen, L.M.5    Guinee, D.J.6
  • 54
    • 0016695728 scopus 로고
    • Porphyria cutanea tarda: Comparison of cases precipitated by alcohol and estrogens
    • Haberman HF, Rosenberg F, Menon IA. Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens. Can Med Assoc J. 1975;113:653-5.
    • (1975) Can Med Assoc J , vol.113 , pp. 653-655
    • Haberman, H.F.1    Rosenberg, F.2    Menon, I.A.3
  • 55
    • 0013963164 scopus 로고
    • Stilbestrol-induced porphyria: Increase in hepatic delta-aminolevulinic acid synthetase
    • Levere RD. Stilbestrol-induced porphyria: increase in hepatic delta-aminolevulinic acid synthetase. Blood. 1966;28:569-72.
    • (1966) Blood , vol.28 , pp. 569-572
    • Levere, R.D.1
  • 56
    • 0022353716 scopus 로고
    • Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication
    • Sixel-Dietrich F, Doss M. Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication. Arch Dermatol Res. 1985;278:13-6.
    • (1985) Arch Dermatol Res , vol.278 , pp. 13-16
    • Sixel-Dietrich, F.1    Doss, M.2
  • 57
    • 0028830816 scopus 로고
    • Occupational porphyria cutanea tarda due to exposure to symmetrical triazine herbicides
    • Altomare G, Capella GL. Occupational porphyria cutanea tarda due to exposure to symmetrical triazine herbicides. Eur J Dermatol. 1995;5:66-8.
    • (1995) Eur J Dermatol , vol.5 , pp. 66-68
    • Altomare, G.1    Capella, G.L.2
  • 58
    • 0022982412 scopus 로고
    • Liver involvement in porphyria
    • Bruguera M. Liver involvement in porphyria. Seminars Dermatol. 1986;5:178-85.
    • (1986) Seminars Dermatol , vol.5 , pp. 178-185
    • Bruguera, M.1
  • 60
    • 0031982781 scopus 로고    scopus 로고
    • High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda
    • Sampietro M, Pipeno A, Lupica L, Arosio C, Vergani A, Corbeta N, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology. 1998;27:181-4.
    • (1998) Hepatology , vol.27 , pp. 181-184
    • Sampietro, M.1    Pipeno, A.2    Lupica, L.3    Arosio, C.4    Vergani, A.5    Corbeta, N.6
  • 62
    • 0007172286 scopus 로고    scopus 로고
    • The role of the hepatitis C virus in the liver disease of porphyria cutanea tarda
    • Quecedo L, Costa J, de Salamanca RE. The role of the hepatitis C virus in the liver disease of porphyria cutanea tarda. Med Clin (Barc). 1996;106:321-4.
    • (1996) Med Clin (Barc) , vol.106 , pp. 321-324
    • Quecedo, L.1    Costa, J.2    de Salamanca, R.E.3
  • 65
    • 0031802747 scopus 로고    scopus 로고
    • High prevalence of hepatitis C virus infection in patients with porphyria cutanea tarda in Poland
    • Dabrowska E, Jablonska-Kaszewska I, Falkiewicz B. High prevalence of hepatitis C virus infection in patients with porphyria cutanea tarda in Poland. Clin Exp Dermatol. 1998;23:95-6.
    • (1998) Clin Exp Dermatol , vol.23 , pp. 95-96
    • Dabrowska, E.1    Jablonska-Kaszewska, I.2    Falkiewicz, B.3
  • 68
    • 12644283534 scopus 로고    scopus 로고
    • Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without HIV
    • Cribier B, Rey D, Uhl G, Le Coz C, Hirth C, Libbrecht E, et al. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without HIV. Arch Dermatol. 1996;132:1448-52.
    • (1996) Arch Dermatol , vol.132 , pp. 1448-1452
    • Cribier, B.1    Rey, D.2    Uhl, G.3    Le Coz, C.4    Hirth, C.5    Libbrecht, E.6
  • 69
    • 0035724150 scopus 로고    scopus 로고
    • The management of porphyria cutanea tarda
    • Sarkany RPE. The management of porphyria cutanea tarda. Clin Exp Dermatol. 2001;26:225-32.
    • (2001) Clin Exp Dermatol , vol.26 , pp. 225-232
    • Sarkany, R.P.E.1
  • 72
    • 0031805078 scopus 로고    scopus 로고
    • Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection
    • Gregorio GV, Pensati P, Iorio R, Vegnente A, Mieli-Vergani G, Vergani D. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol. 1998;112:471-6
    • (1998) Clin Exp Immunol , vol.112 , pp. 471-476
    • Gregorio, G.V.1    Pensati, P.2    Iorio, R.3    Vegnente, A.4    Mieli-Vergani, G.5    Vergani, D.6
  • 73
    • 0028968501 scopus 로고
    • Porphyria cutanea tarda and hepatitis C virus and B virus infection: A retrospective study
    • Navas S, Bosch P, Castillo I, Marriott E, Carreno V. Porphyria cutanea tarda and hepatitis C virus and B virus infection: a retrospective study. Hepatology. 1995;21:279-84.
    • (1995) Hepatology , vol.21 , pp. 279-284
    • Navas, S.1    Bosch, P.2    Castillo, I.3    Marriott, E.4    Carreno, V.5
  • 75
    • 85047692916 scopus 로고
    • Porphyria cutanea tarda in association with human immunodeficiency virus infection: Is it related to hepatitis C virus infection?
    • Castanet J, Lacour JP, Bodokh I, Bekri S, Ortonne JP. Porphyria cutanea tarda in association with human immunodeficiency virus infection: is it related to hepatitis C virus infection? Arch Dermatol. 1994;130:664-5.
    • (1994) Arch Dermatol , vol.130 , pp. 664-665
    • Castanet, J.1    Lacour, J.P.2    Bodokh, I.3    Bekri, S.4    Ortonne, J.P.5
  • 76
    • 0032907166 scopus 로고    scopus 로고
    • Porphyria cutanea tarda and HIV/AIDS: A review of pathogenesis, clinical manifestations and management
    • Mansourati FF, Stone VE, Mayer KH. Porphyria cutanea tarda and HIV/AIDS: a review of pathogenesis, clinical manifestations and management. Int J STD AIDS. 1999;10:51-6.
    • (1999) Int J STD AIDS , vol.10 , pp. 51-56
    • Mansourati, F.F.1    Stone, V.E.2    Mayer, K.H.3
  • 77
    • 0027447204 scopus 로고
    • Porphyria cutanea tarda in the setting of renal failure: Response to renal transplantation
    • Stevens BR, Fleischer AB Jr, Piering F, Crosby DL. Porphyria cutanea tarda in the setting of renal failure: response to renal transplantation. Arch Dermatol. 1993;129:337-9.
    • (1993) Arch Dermatol , vol.129 , pp. 337-339
    • Stevens, B.R.1    Fleischer Jr, A.B.2    Piering, F.3    Crosby, D.L.4
  • 79
    • 0018070910 scopus 로고
    • Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda
    • Elder GH, Path MRC, Lee GB, Tovey JA. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Engl J Med. 1978;299:274-8.
    • (1978) N Engl J Med , vol.299 , pp. 274-278
    • Elder, G.H.1    Path, M.R.C.2    Lee, G.B.3    Tovey, J.A.4
  • 81
    • 0022577883 scopus 로고
    • Uroporphyrinogen- decarboxylase deficiencies: Porphyria cutanea tarda and related conditions
    • Mascaro JM, Herrero C, Lecha M, Muniesa AM. Uroporphyrinogen- decarboxylase deficiencies: porphyria cutanea tarda and related conditions. Semin Dermatol. 1986;5:115-24.
    • (1986) Semin Dermatol , vol.5 , pp. 115-124
    • Mascaro, J.M.1    Herrero, C.2    Lecha, M.3    Muniesa, A.M.4
  • 82
    • 0029620415 scopus 로고
    • The Porphyrias: A brief overview based on 25 years of experience (1969-1994) by the department of dermatology of the hospital clinic and faculty of medicine of Barcelona, Spain
    • Mascaro JM. The Porphyrias: a brief overview based on 25 years of experience (1969-1994) by the department of dermatology of the hospital clinic and faculty of medicine of Barcelona, Spain. J Dermatol. 1995;22:823-8.
    • (1995) J Dermatol , vol.22 , pp. 823-828
    • Mascaro, J.M.1
  • 83
    • 0028937286 scopus 로고
    • Hypertrichosis as the presenting feature of porphyria cutanea tarda
    • Boffa MJ, Reed P, Weinkove C, Ead RD. Hypertrichosis as the presenting feature of porphyria cutanea tarda. Clin Exp Dermatol. 1995;20:62-4.
    • (1995) Clin Exp Dermatol , vol.20 , pp. 62-64
    • Boffa, M.J.1    Reed, P.2    Weinkove, C.3    Ead, R.D.4
  • 84
    • 0032475906 scopus 로고    scopus 로고
    • The significance of histologic analysis of skin lesions in porphyria cutanea tarda. Light microscopy, electron microscopy, immunohistochemical and immunofluorescence analysis
    • Krajnc I, Vizjak A, Hvala A, Jurcic V, Rozman B. The significance of histologic analysis of skin lesions in porphyria cutanea tarda. Light microscopy, electron microscopy, immunohistochemical and immunofluorescence analysis. Wien Klin Wochenschr. 1998;110:651-4.
    • (1998) Wien Klin Wochenschr , vol.110 , pp. 651-654
    • Krajnc, I.1    Vizjak, A.2    Hvala, A.3    Jurcic, V.4    Rozman, B.5
  • 85
    • 0020912687 scopus 로고
    • Porphyria and scleroderma: A clinical and laboratorial review of 12 patients
    • Doyle JA, Friedman SJ. Porphyria and scleroderma: a clinical and laboratorial review of 12 patients. Australas J Dermatol. 1983;24:109-14.
    • (1983) Australas J Dermatol , vol.24 , pp. 109-114
    • Doyle, J.A.1    Friedman, S.J.2
  • 89
    • 0025933801 scopus 로고
    • Porphyria cutanea tarda: Clinical manifestations
    • Mascaro JM. Porphyria cutanea tarda: clinical manifestations. Curr Probl Dermatol. 1991;20:79-90.
    • (1991) Curr Probl Dermatol , vol.20 , pp. 79-90
    • Mascaro, J.M.1
  • 90
    • 0023087957 scopus 로고
    • Demonstration of needle-shaped hepatic inclusions in porphyria cutanea tarda using the ferric ferricyanide reduction test
    • Fakan F, Chlumska A. Demonstration of needle-shaped hepatic inclusions in porphyria cutanea tarda using the ferric ferricyanide reduction test. Virchows Arch A Pathol Anat Histopathol. 1987;411:365-8.
    • (1987) Virchows Arch A Pathol Anat Histopathol , vol.411 , pp. 365-368
    • Fakan, F.1    Chlumska, A.2
  • 91
    • 0018969946 scopus 로고
    • Demonstration of cytoplasmic needle-like inclusions in hepatocytes with porphyria cutanea tarda
    • James KA, Cortes JM, Paradinas FJ. Demonstration of cytoplasmic needle-like inclusions in hepatocytes with porphyria cutanea tarda. J Clin Pathol. 1980;33:899-900.
    • (1980) J Clin Pathol , vol.33 , pp. 899-900
    • James, K.A.1    Cortes, J.M.2    Paradinas, F.J.3
  • 92
    • 0034800677 scopus 로고    scopus 로고
    • Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease
    • Fracanzani AL, Taioli E, Sampietro M, Fatta E, Bertelli C, Fiorelli G, et al. Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease. J Hepatol. 2001;35:498-503.
    • (2001) J Hepatol , vol.35 , pp. 498-503
    • Fracanzani, A.L.1    Taioli, E.2    Sampietro, M.3    Fatta, E.4    Bertelli, C.5    Fiorelli, G.6
  • 93
    • 0021867192 scopus 로고
    • Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors
    • Salata H, Cortes JM, Enriquez de Salamanca R, Oliva H, Castro A, Kusak E, et al. Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors. J Hepatol. 1985;1:477-87.
    • (1985) J Hepatol , vol.1 , pp. 477-487
    • Salata, H.1    Cortes, J.M.2    Enriquez de Salamanca, R.3    Oliva, H.4    Castro, A.5    Kusak, E.6
  • 94
    • 0028798608 scopus 로고
    • The porphyries and hepatocelular carcinoma
    • Lim HW, Mascaro JM. The porphyries and hepatocelular carcinoma. Dermatol Clin. 1995;13:135-42.
    • (1995) Dermatol Clin , vol.13 , pp. 135-142
    • Lim, H.W.1    Mascaro, J.M.2
  • 95
    • 0026632886 scopus 로고
    • Hepatocellular carcinoma in porphyria cutanea tarda: Frequency and factors related to its occurrence
    • Siersema PD, ten Kate FJW, Mulder PGH, Wilson JHP. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver. 1992;12:56-61.
    • (1992) Liver , vol.12 , pp. 56-61
    • Siersema, P.D.1    ten Kate, F.J.W.2    Mulder, P.G.H.3    Wilson, J.H.P.4
  • 98
    • 0020063271 scopus 로고
    • Porphyria cutanea tarda and systemic lupus erythematosus
    • Clemmensen O, Thomsen K. Porphyria cutanea tarda and systemic lupus erythematosus. Arch Dermatol. 1982;118:160-2.
    • (1982) Arch Dermatol , vol.118 , pp. 160-162
    • Clemmensen, O.1    Thomsen, K.2
  • 99
    • 0029741790 scopus 로고    scopus 로고
    • Discoid lupus erythematosus and porphyria cutanea tarda
    • O'Reilly FM, O'Loughlin S, Murphy GM. Discoid lupus erythematosus and porphyria cutanea tarda. J R Soc Med. 1996;89:523-4.
    • (1996) J R Soc Med , vol.89 , pp. 523-524
    • O'Reilly, F.M.1    O'Loughlin, S.2    Murphy, G.M.3
  • 100
    • 0025271259 scopus 로고
    • Porphyria cutanea tarda after allogenic bone marrow transplantation for chronic myelogenous leukemia
    • Guyotat D, Nicolas JF, Augey F, Fiere D, Thivolet J. Porphyria cutanea tarda after allogenic bone marrow transplantation for chronic myelogenous leukemia. Am J Hematol. 1990;34:69-70.
    • (1990) Am J Hematol , vol.34 , pp. 69-70
    • Guyotat, D.1    Nicolas, J.F.2    Augey, F.3    Fiere, D.4    Thivolet, J.5
  • 101
    • 0004044171 scopus 로고
    • Dermatological photobiology. Clinical and experimental aspects
    • London: Blackwell Scientific;
    • Magnus IA. Dermatological photobiology. Clinical and experimental aspects. Appendix II - Clinical screening tests for excess porphyrins. London: Blackwell Scientific; 1976. p.253-5.
    • (1976) Appendix II - Clinical screening tests for excess porphyrins , pp. 253-255
    • Magnus, I.A.1
  • 102
    • 0021358220 scopus 로고
    • Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias
    • Lim CK, Peters TJ. Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. Clin Chim Acta. 1984;139:55-63.
    • (1984) Clin Chim Acta , vol.139 , pp. 55-63
    • Lim, C.K.1    Peters, T.J.2
  • 103
    • 0003115612 scopus 로고
    • Biochemical diagnosis of the cutaneous porphyrias: Five years experience of plasma spectrofluorimetry [abstract]
    • Gibbs NK, Traynor N, Ferguson J. Biochemical diagnosis of the cutaneous porphyrias: five years experience of plasma spectrofluorimetry [abstract]. Br J Dermatol. 1995;133:18.
    • (1995) Br J Dermatol , vol.133 , pp. 18
    • Gibbs, N.K.1    Traynor, N.2    Ferguson, J.3
  • 105
    • 0025913273 scopus 로고
    • Skin morphology in porphyria cutanea tarda does not improve despite clinical remission
    • Timonen K, Niemi KM, Mustajoki P. Skin morphology in porphyria cutanea tarda does not improve despite clinical remission. Clin Exp Dermatol. 1991;16:355-8.
    • (1991) Clin Exp Dermatol , vol.16 , pp. 355-358
    • Timonen, K.1    Niemi, K.M.2    Mustajoki, P.3
  • 106
    • 0017260703 scopus 로고
    • Mouse model for protoporphyria. III. Experimental production of chronic erythropoietic protoporphyria-like skin lesions
    • Hönigsmann H, Gschnaiat F, Konrad K, Stingl G, Wolff K. Mouse model for protoporphyria. III. Experimental production of chronic erythropoietic protoporphyria-like skin lesions. J Invest Dermatol. 1976;66:188-95.
    • (1976) J Invest Dermatol , vol.66 , pp. 188-195
    • Hönigsmann, H.1    Gschnaiat, F.2    Konrad, K.3    Stingl, G.4    Wolff, K.5
  • 107
    • 0013962435 scopus 로고
    • Histochemistry of the skin in erythropoietic protoporphyria
    • Ryan EA. Histochemistry of the skin in erythropoietic protoporphyria. Br J Dermatol. 1966;78:501-18.
    • (1966) Br J Dermatol , vol.78 , pp. 501-518
    • Ryan, E.A.1
  • 109
    • 0025736261 scopus 로고
    • Studies of laminin and type IV collagen in blisters of porphyria cutanea tarda and drug-induced pseudoporphyria
    • Dabski C, Beutner EH. Studies of laminin and type IV collagen in blisters of porphyria cutanea tarda and drug-induced pseudoporphyria. J Am Acad Dermatol. 1991;25:28-32.
    • (1991) J Am Acad Dermatol , vol.25 , pp. 28-32
    • Dabski, C.1    Beutner, E.H.2
  • 110
    • 0021084424 scopus 로고
    • Junctional blisters in acquired bullous disorders of the dermal-epidermal junction zone: Role of the lamina lucida as the mechanical locus minoris resistentiae
    • Klein GF, Hintner H, Schuler G, Fritsch P. Junctional blisters in acquired bullous disorders of the dermal-epidermal junction zone: role of the lamina lucida as the mechanical locus minoris resistentiae. Br J Dermatol. 1983;109:499-508.
    • (1983) Br J Dermatol , vol.109 , pp. 499-508
    • Klein, G.F.1    Hintner, H.2    Schuler, G.3    Fritsch, P.4
  • 111
    • 0015971980 scopus 로고
    • The treatment of porphyria cutanea tarda by venesection
    • Ramsay CA, Magnus IA, Turnbull A, Baker H. The treatment of porphyria cutanea tarda by venesection. Q J Med. 1974;43:1-24.
    • (1974) Q J Med , vol.43 , pp. 1-24
    • Ramsay, C.A.1    Magnus, I.A.2    Turnbull, A.3    Baker, H.4
  • 112
    • 25944452669 scopus 로고
    • Allgemeinsymptome der späten Hautporphyrie (Porphyria Cutanea Tarda) als Hinweise für deren Behandlung
    • Ippen H. Allgemeinsymptome der späten Hautporphyrie (Porphyria Cutanea Tarda) als Hinweise für deren Behandlung. Dtsche Med Wochenschr. 1961;86:127-33.
    • (1961) Dtsche Med Wochenschr , vol.86 , pp. 127-133
    • Ippen, H.1
  • 113
    • 46149140088 scopus 로고
    • Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda
    • Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Borghi A, Ventura E. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda. J Lab Clin Méd. 1986;107:36-42.
    • (1986) J Lab Clin Méd , vol.107 , pp. 36-42
    • Rocchi, E.1    Gibertini, P.2    Cassanelli, M.3    Pietrangelo, A.4    Borghi, A.5    Ventura, E.6
  • 114
    • 0035886631 scopus 로고    scopus 로고
    • Hereditary haemochromatosis: Detection and management
    • Vautier G, Murray M, Olnyk JK. Hereditary haemochromatosis: detection and management. Med J Aust. 2001;175:418-21.
    • (2001) Med J Aust , vol.175 , pp. 418-421
    • Vautier, G.1    Murray, M.2    Olnyk, J.K.3
  • 115
    • 0016405032 scopus 로고
    • A clinical evaluation of serum ferritin as an index of iron stores
    • Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974;290:1213-6.
    • (1974) N Engl J Med , vol.290 , pp. 1213-1216
    • Lipschitz, D.A.1    Cook, J.D.2    Finch, C.A.3
  • 116
    • 0024246704 scopus 로고
    • Plasma ferritin levels as a guide to the treatment of porphyria cutanea tarda by venesection
    • Ratnaike S, Blake D, Campbell D Cowen P, Varigos G. Plasma ferritin levels as a guide to the treatment of porphyria cutanea tarda by venesection. Australas J Dermatol. 1988;29:3-8.
    • (1988) Australas J Dermatol , vol.29 , pp. 3-8
    • Ratnaike, S.1    Blake, D.2    Campbell, D.3    Cowen, P.4    Varigos, G.5
  • 117
    • 0019454077 scopus 로고
    • A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda
    • Malina L, Chlumsky J. A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda. Acta Derm Venereol. 1981;61:346-50.
    • (1981) Acta Derm Venereol , vol.61 , pp. 346-350
    • Malina, L.1    Chlumsky, J.2
  • 118
    • 0036441169 scopus 로고    scopus 로고
    • Porphyria cutanea tarda in south-east New South Wales
    • McCrossin I. Porphyria cutanea tarda in south-east New South Wales. Austral J Dermatol. 2002;43:285-8.
    • (2002) Austral J Dermatol , vol.43 , pp. 285-288
    • McCrossin, I.1
  • 119
    • 0018975638 scopus 로고
    • Hydroxychloroquine treatment of porphyria cutanea tarda
    • Malkinson FD, Levitt L. Hydroxychloroquine treatment of porphyria cutanea tarda. Arch Dermatol. 1980;116:1147-50.
    • (1980) Arch Dermatol , vol.116 , pp. 1147-1150
    • Malkinson, F.D.1    Levitt, L.2
  • 120
    • 0029039203 scopus 로고
    • Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda
    • Liu AC. Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda. West J Med. 1995;162:548-51.
    • (1995) West J Med , vol.162 , pp. 548-551
    • Liu, A.C.1
  • 121
    • 70449142355 scopus 로고
    • Porphyria cutanea tarda: Report of a case successfully treated with chloroquine
    • London ID. Porphyria cutanea tarda: report of a case successfully treated with chloroquine. Arch Dermatol. 1957;75:801-3.
    • (1957) Arch Dermatol , vol.75 , pp. 801-803
    • London, I.D.1
  • 122
    • 0021703436 scopus 로고
    • Low-dose oral chloroquine in the treatment of porphyria cutanea tarda
    • Ashton RE, Hawk JLM, Magnus IA. Low-dose oral chloroquine in the treatment of porphyria cutanea tarda. Br J Dermatol. 1981;111:609-13.
    • (1981) Br J Dermatol , vol.111 , pp. 609-613
    • Ashton, R.E.1    Hawk, J.L.M.2    Magnus, I.A.3
  • 123
    • 0017331725 scopus 로고
    • Chloroquine in the treatment of porphyria cutanea tarda
    • Kordac V, Papezová R, Semrádová M. Chloroquine in the treatment of porphyria cutanea tarda. N Eng J Med. 1977;296:949.
    • (1977) N Eng J Med , vol.296 , pp. 949
    • Kordac, V.1    Papezová, R.2    Semrádová, M.3
  • 124
    • 0024371206 scopus 로고
    • Agents affecting porphyrin formation and secretion: Implications for porphyria cutanea tarda treatment
    • Kordac V, Jirsa M, Kotal P, Kalab M, Cervinka J, Kotyk A, et al. Agents affecting porphyrin formation and secretion: implications for porphyria cutanea tarda treatment. Semin Hematol. 1989;26:16-23.
    • (1989) Semin Hematol , vol.26 , pp. 16-23
    • Kordac, V.1    Jirsa, M.2    Kotal, P.3    Kalab, M.4    Cervinka, J.5    Kotyk, A.6
  • 125
    • 0029049518 scopus 로고
    • Treatment of porphyria cutanea tarda by the effect of chloroquine on the liver
    • Freesemann A, Frank M, Sieg I, Doss MO. Treatment of porphyria cutanea tarda by the effect of chloroquine on the liver. Skin Pharmacol. 1995;8:156-61.
    • (1995) Skin Pharmacol , vol.8 , pp. 156-161
    • Freesemann, A.1    Frank, M.2    Sieg, I.3    Doss, M.O.4
  • 126
    • 0018843393 scopus 로고
    • Liver changes in porphyria cutanea tarda patients treated with chloroquine
    • Chlumska A, Chlumska J, Malina L. Liver changes in porphyria cutanea tarda patients treated with chloroquine. Br J Dermatol. 1980;102:261-6.
    • (1980) Br J Dermatol , vol.102 , pp. 261-266
    • Chlumska, A.1    Chlumska, J.2    Malina, L.3
  • 127
    • 0028303176 scopus 로고
    • Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload
    • Valls V, Ena J, Enriquez de Salamanca R. Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload. J Dermatol Sci. 1994;7:169-75.
    • (1994) J Dermatol Sci , vol.7 , pp. 169-175
    • Valls, V.1    Ena, J.2    Enriquez de Salamanca, R.3
  • 129
    • 0021991177 scopus 로고
    • Influence of chloroquine on the porphyrin metabolism
    • Goerz G, Bolsen K, Merk H. Influence of chloroquine on the porphyrin metabolism. Arch Dermatol Res. 1985;277:114-7.
    • (1985) Arch Dermatol Res , vol.277 , pp. 114-117
    • Goerz, G.1    Bolsen, K.2    Merk, H.3
  • 130
    • 0015816966 scopus 로고
    • The molecular basis of the action of chloroquine in porphyria cutanea tarda
    • Scholnick PL, Epstein JH, Marver HS. The molecular basis of the action of chloroquine in porphyria cutanea tarda. J Invest Dermatol. 1973;61:226-32.
    • (1973) J Invest Dermatol , vol.61 , pp. 226-232
    • Scholnick, P.L.1    Epstein, J.H.2    Marver, H.S.3
  • 131
    • 0025321467 scopus 로고
    • Ergebnisse bei der Behandlung der Porphyria cutanea tarda mit Aderlass und Resorchin
    • Seubert S, Seubert A, Stella AM, Guzman H, Batlle A. Ergebnisse bei der Behandlung der Porphyria cutanea tarda mit Aderlass und Resorchin. Z Hautkr. 1990;65:223-5.
    • (1990) Z Hautkr , vol.65 , pp. 223-225
    • Seubert, S.1    Seubert, A.2    Stella, A.M.3    Guzman, H.4    Batlle, A.5
  • 132
    • 0030891581 scopus 로고    scopus 로고
    • Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C
    • Okano J, Horie Y, Kawasaki H, Kondo M. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C. Hepatogastroenterology. 1997;44:525-8.
    • (1997) Hepatogastroenterology , vol.44 , pp. 525-528
    • Okano, J.1    Horie, Y.2    Kawasaki, H.3    Kondo, M.4
  • 133
    • 15444345904 scopus 로고    scopus 로고
    • Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C
    • Sheikh MY, Wright RA, Burruss JB. Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C. Dig Dis Sci. 1998;43:529-33.
    • (1998) Dig Dis Sci , vol.43 , pp. 529-533
    • Sheikh, M.Y.1    Wright, R.A.2    Burruss, J.B.3
  • 135
    • 0027214149 scopus 로고
    • Treatment of porphyria cutanea tarda of end stage renal disease with erythropoietin
    • Sarkell B, Patterson JW. Treatment of porphyria cutanea tarda of end stage renal disease with erythropoietin. J Am Acad Dermatol. 1993;29:499-500.
    • (1993) J Am Acad Dermatol , vol.29 , pp. 499-500
    • Sarkell, B.1    Patterson, J.W.2
  • 136
    • 0030857480 scopus 로고    scopus 로고
    • Porphyria cutanea tarda in a dialyzed patient with hepatitis C virus infection: Dramatic efficacy of small repeated phlebotomies
    • Poux JM, Demontis R, Cadranel JF, Ghazali A, Fievet P, Nordmann Y. Porphyria cutanea tarda in a dialyzed patient with hepatitis C virus infection: dramatic efficacy of small repeated phlebotomies. Am J Med. 1997;103:163-4.
    • (1997) Am J Med , vol.103 , pp. 163-164
    • Poux, J.M.1    Demontis, R.2    Cadranel, J.F.3    Ghazali, A.4    Fievet, P.5    Nordmann, Y.6
  • 137
    • 0031048785 scopus 로고    scopus 로고
    • Renal transplantation for porphyria cutanea tarda
    • Ewing S, Crosby DL. Renal transplantation for porphyria cutanea tarda. N Engl J Med. 1997;336:811.
    • (1997) N Engl J Med , vol.336 , pp. 811
    • Ewing, S.1    Crosby, D.L.2
  • 138
    • 0022624568 scopus 로고
    • Iron removal therapy in porphyria cutanea tarda: Phlebotomy versus slow subcutaneous desferrioxamine infusion
    • Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Borghi A, Pantaleoni M, et al. Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion. Br J Dermatol. 1986;114:621-9.
    • (1986) Br J Dermatol , vol.114 , pp. 621-629
    • Rocchi, E.1    Gibertini, P.2    Cassanelli, M.3    Pietrangelo, A.4    Borghi, A.5    Pantaleoni, M.6
  • 139
    • 0014009049 scopus 로고
    • Porphyrin-binding effect of cholestyramine. Results of in vitro and in vivo studies
    • Stathers GM. Porphyrin-binding effect of cholestyramine. Results of in vitro and in vivo studies. Lancet. 1966;2:780-3.
    • (1966) Lancet , vol.2 , pp. 780-783
    • Stathers, G.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.